Amgen and the ACVP/STP Coalition for Veterinary Pathology Fellows
Dr. Esther Trueblood and Dean Slinker at the
2009 Celebration of Excellence
Responding to current and predicted shortages of well-trained veterinary anatomic and clinical pathologists, the ACVP/STP Coalition for Veterinary Pathology Fellows selected Washington State University’s College of Veterinary Medicine as one of 10 institutions for Anatomic Pathology Residencies. The positions are competitively awarded to training programs based on the past performance of graduates and the current training program and environment, including faculty and caseload available for training purposes. “The receipt of an ACVP/STP Coalition Fellowship by WSU is evidence of the past and current excellence of WSU’s training program in veterinary pathology. These highly competitive positions are awarded to only the finest veterinary pathology training programs in North America,” said Dr. Gary Cockerell, director of the ACVP/STP Coalition for Veterinary Pathology Fellows.
The ACVP/STP Coalition for Veterinary Pathology Fellows represents a unique partnership between the highest quality North American academic training programs and world-class biopharmaceutical companies to provide much-needed, well trained veterinary pathologists.
Funding for the WSU position was provided by Amgen, a leading human therapeutics company in the biotechnology industry. “Valuable support from Amgen, through the ACVP/STP Coalition, not only allows WSU to train additional anatomic pathologists, addressing a critical shortage of highly qualifi ed specialists in the global biomedical community but also greatly enhances the training experience by fostering direct, on-site, face-to-face interactions of the Fellow and academic training department with biotechnology and pharmaceutical industry sponsors,” said Dr. Tim Baszler, professor, Department of Veterinary Microbiology and Pathology, and director, Washington Animal Disease Diagnostic Laboratory.